Scientists Discover How Cell Surface Protein Drives Deadly Inflammation in Arteries
New research reveals how nucleolin protein triggers inflammatory cell death in blood vessels, potentially opening new treatment paths.
Summary
Scientists have identified how a protein called nucleolin promotes dangerous inflammation in artery walls, contributing to atherosclerosis progression. Using mouse models, researchers found that nucleolin on cell surfaces interacts with another protein (RASSF2) to trigger pyroptosis - an inflammatory form of cell death in endothelial cells lining blood vessels. When they blocked nucleolin or the inflammation pathway, arterial damage was significantly reduced. This discovery reveals a new molecular mechanism driving atherosclerosis and suggests potential therapeutic targets for preventing cardiovascular disease through reducing vascular inflammation.
Detailed Summary
Atherosclerosis, the buildup of plaque in arteries leading to heart attacks and strokes, involves complex inflammatory processes that damage blood vessel walls. This new research identifies a previously unknown mechanism by which a protein called nucleolin promotes this deadly inflammation.
Researchers used atherosclerosis-prone mice fed high-fat diets and examined their aortic tissues alongside cultured endothelial cells exposed to oxidized LDL cholesterol. They employed advanced techniques including immunoprecipitation-mass spectrometry to map protein interactions and assess inflammatory cell death patterns.
The study revealed that nucleolin on endothelial cell surfaces interacts with RASSF2 protein, facilitating its transport into cell nuclei where it triggers pyroptosis - an inflammatory form of programmed cell death. Mice with severe arterial lesions showed elevated nucleolin expression and extensive endothelial cell pyroptosis. Crucially, when researchers knocked down nucleolin or inhibited the NLRP3 inflammasome pathway, both arterial damage and inflammatory cell death were significantly reduced.
For longevity and cardiovascular health, this discovery is significant because it identifies a new therapeutic target for preventing atherosclerosis progression. By understanding how nucleolin drives vascular inflammation, researchers can potentially develop interventions to protect endothelial cells and maintain healthy blood vessels - critical for longevity since cardiovascular disease remains a leading cause of premature death.
However, this research was conducted in mouse models and cell cultures, so human clinical validation is needed. The complexity of atherosclerosis involves multiple pathways, meaning nucleolin represents just one piece of the puzzle in developing comprehensive cardiovascular protection strategies.
Key Findings
- Nucleolin protein on cell surfaces promotes inflammatory cell death in artery-lining endothelial cells
- Blocking nucleolin significantly reduced arterial plaque formation in atherosclerosis-prone mice
- Nucleolin works by transporting RASSF2 protein into cell nuclei to trigger pyroptosis
- Inhibiting the NLRP3 inflammasome pathway also reduced both inflammation and arterial damage
Methodology
Researchers used ApoE-/- mice fed high-fat diets to induce atherosclerosis, then assessed aortic lesions and endothelial cell death patterns. They also used cultured endothelial cells treated with oxidized LDL and employed immunoprecipitation-mass spectrometry to identify protein interactions.
Study Limitations
This study was conducted entirely in mouse models and cell cultures, requiring human clinical validation. Atherosclerosis involves multiple complex pathways, so nucleolin represents only one potential intervention point in this multifaceted disease process.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.